Rendu Bio's HBV DNA High-Sensitivity Quantitative Assay Approved for Launch in China! Pioneering Dual-Pathway HBV DNA+RNA Testing Paradigm!

From March 26 to 30, 2025, the 34th Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL) was held at the China National Convention Center in Beijing. Centered around the theme "Diverse Partnerships: Creating Miracles...

The 34th APASL Annual Meeting will take place in Beijing from March 26th to 30th. We will showcase Rendu’s comprehensive solutions, including Hepatitis B RNA and Hepatitis C RNA testing systems, highlighting high-sensitivity and precise molecular....

Rendu's New Products Coming Soon, Small Space, Big Capacity!

Recently, Rendu Biotech and India's renowned company, Green Apple Medical System, officially signed a strategic cooperation agreement in Shanghai. This collaboration marks a significant milestone in Rendu Biotech's international expansion.....